Cargando…
Computationally driven discovery of phenyl(piperazin-1-yl)methanone derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors
Monoacylglycerol lipase (MAGL) is an attractive therapeutic target for many pathologies, including neurodegenerative diseases, cancer as well as chronic pain and inflammatory pathologies. The identification of reversible MAGL inhibitors, devoid of the side effects associated to prolonged MAGL inacti...
Autores principales: | Poli, Giulio, Lapillo, Margherita, Jha, Vibhu, Mouawad, Nayla, Caligiuri, Isabella, Macchia, Marco, Minutolo, Filippo, Rizzolio, Flavio, Tuccinardi, Tiziano, Granchi, Carlotta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352951/ https://www.ncbi.nlm.nih.gov/pubmed/30696302 http://dx.doi.org/10.1080/14756366.2019.1571271 |
Ejemplares similares
-
Discovery of Monoacylglycerol Lipase (MAGL) Inhibitors Based on a Pharmacophore-Guided Virtual Screening Study
por: Jha, Vibhu, et al.
Publicado: (2020) -
Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors
por: Granchi, Carlotta, et al.
Publicado: (2017) -
Binding investigation and preliminary optimisation of the 3-amino-1,2,4-triazin-5(2H)-one core for the development of new Fyn inhibitors
por: Poli, Giulio, et al.
Publicado: (2018) -
Reversible Monoacylglycerol
Lipase Inhibitors: Discovery
of a New Class of Benzylpiperidine Derivatives
por: Bononi, Giulia, et al.
Publicado: (2022) -
Monoacylglycerol Lipase (MAGL) Inhibition Attenuates Acute Lung Injury in Mice
por: Costola-de-Souza, Carolina, et al.
Publicado: (2013)